Cargando…

New sepsis-related marker: endotoxin activity assay

Detalles Bibliográficos
Autores principales:	Ikeda, T, Ikeda, K, Taniuchi, H, Hiramatsu, M, Suda, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254930/ http://dx.doi.org/10.1186/cc9115

Ejemplares similares

Background factors in patients receiving immunoglobulin administration and changes in sepsis markers
por: Ikeda, T, et al.
Publicado: (2010)

Usefulness of the endotoxin activity assay as a biomarker to assess severity in ICU patients
por: Noguchi, M, et al.
Publicado: (2014)

Endotoxin assay with endotoxin scattering photometry is one of the diagnostic markers of sepsis
por: Kase, Y, et al.
Publicado: (2010)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Usefulness of endotoxin activity assay for early diagnosis of sepsis
por: Sekine, S, et al.
Publicado: (2015)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

Newly developed endotoxin measurement method (endotoxin activity assay) may reflect the severity of sepsis
por: Murayama, H, et al.
Publicado: (2009)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Early diagnosis of sepsis due to Gram-negative infection with the Endotoxin Activity Assay
por: Kang, M, et al.
Publicado: (2014)

Can urinary 8-OHdG be a good indicator of vasospasm occurrence following subarachnoid hemorrhage?
por: Ikeda, K, et al.
Publicado: (2012)

Comparison of the effects of recombinant human soluble thrombomodulin for systemic inflammatory response syndrome-associated coagulopathy with and without continuous hemodiafiltration
por: Matsuo, SM, et al.
Publicado: (2011)

Investigation into problems associated with the endotoxin activity assay
por: Matsumoto, N, et al.
Publicado: (2011)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Anti-endotoxin immunity in abdominal sepsis patients
por: Butyrsky, O, et al.
Publicado: (2011)

Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers
por: Atagi, K
Publicado: (2011)

Effects of inhaled carbon monoxide and glucocorticoids in porcine endotoxin sepsis
por: Koulouras, V, et al.
Publicado: (2008)

Endotoxin Activity Assay levels correlate with the microbiological results of Gram-negative organisms in septic patients
por: Tsunoda, M, et al.
Publicado: (2014)

The effect of endotoxin adsorber hemoperfusion on microcirculation in patients with severe sepsis and septic shock
por: Yeh, Y-C, et al.
Publicado: (2015)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Marker or mediator? Changes in endotoxin activity as a predictor of adverse outcomes in critical illness
por: Klein, D, et al.
Publicado: (2005)

Effects of steroid therapies to severe streptococcal pneumoniae that required mechanical ventilation
por: Nagura, T, et al.
Publicado: (2013)

Microdialysis: an innovative new tool to detect endotoxin tolerance
por: Staubach, K, et al.
Publicado: (2004)

Measuring endotoxin with newly developed endotoxin scattering photometry
por: Kase, Y, et al.
Publicado: (2008)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Increased endotoxin activity is associated with clinical deterioration in moderate-severity emergency department sepsis patients: a pilot study
por: Arnold, R, et al.
Publicado: (2012)

The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models
por: Shirakawa, K, et al.
Publicado: (2010)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Clinical usefulness of measuring endotoxin activity on ICU admission
por: Murai, A, et al.
Publicado: (2012)

New markers of inflammation-induced renal injury subside when endotoxin tolerance develops in humans as measured by urine proteomics
por: Heemskerk, S, et al.
Publicado: (2010)

Endotoxin enhances the fibrinolytic activity of monocytes incorporated in a fibrin clot
por: Grosjean, A, et al.
Publicado: (2005)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients
por: Ikeda, T, et al.
Publicado: (2015)

Endotoxin induces conversion of endothelial cells into activated fibroblasts
por: Echeverría, César, et al.
Publicado: (2013)

Endotoxin impairs the human pacemaker current I(f)
por: Zorn-Pauly, K, et al.
Publicado: (2008)

Prevalence and clinical significance of early endotoxin activity in septic shock patients
por: Bottiroli, M, et al.
Publicado: (2015)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Serum procalcitonin level correlates with endotoxin activity in patients with septic shock
por: Adamik, B, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c21k8nohi2lbjkdrgp5boql0tk